advertisement
advertisement
Current Issue
January Extra 2023
The January Extra issue of AUANews is online! Read every article, search by topic and other keywords, all from the comfort of your digital device!
View by Topics
Top 4 Articles
Antibiotic Therapy for Common Stone Procedures: What Is the Optimal Duration?
By: Shane Kronstedt, BS; Jonathan E. Katz, MD; Roger L. Sur, MD
November 2022
Shock Wave Therapy for Erectile Dysfunction: Patterns of Care and Efficacy
By: Juan J. Andino, MD, MBA; Jeffrey C. Morrison, MD; Sriram Eleswarapu, MD; Jesse N. Mills, MD
November 2022
Disproportionate Effects of Prostate Cancer in Black Men: The ConDUC Initiative
By: Arthur L. Burnett, MD, MBA
November 2022
Thulium Lasers Blast into the World of Endourology
By: Arshia Aalami Harandi, MS; Alexander Small, MD
June 2022
Journal Insights
January 2023
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer
Current first-line treatment for advanced urothelial carcinoma (aUC) is platinum-based (preferably cisplatin) combination chemotherapy. In the second-line setting, pembrolizumab immunotherapy is standard. Taxane chemotherapy had shown single-agent activity. We sought to evaluate the combination of nab-paclitaxel (NAB) and pembrolizumab in patients with cisplatin-ineligible or platinum-refractory aUC.
Collections
Out of Office
Have you ever wondered what your favorite urologists do in their spare time? From piloting planes to living on a fully operational farm, learn more about their stories here.
Diversity
Use "Celebrating Diversity with the AUA" focus issues as resources for years to come.
Prostate Cancer
These Highlight Issues feature state-of-the-art research in the advancement of treatment of prostate cancer.
Kidney Stones
These Highlight Issues feature state-of-the-art reserch in the advancement of treatment of kidney stones.